Kimberly Sue, MD, PhD
Harm Reduction Coalition
- Discuss the key guiding principles of harm reduction in the context of working with individuals who use drugs.
- Understand the evidence demonstrating how harm reduction approaches can improve patient engagement and clinical outcomes.
- Describe harm reduction techniques or skills that a practitioner can employ in his/her practice in the near future.
- Discuss harm reduction resources in New York State.
The target audience is health care professional interested in HIV/HCV/STD/DUH continuing medical education.
The University of Rochester School of Medicine and Dentistry is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Rochester School of Medicine and Dentistry designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The University of Rochester Center for Nursing Professional Development is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
1.0 Nursing Contact Hours will be provided.
The University at Buffalo School of Pharmacy and Pharmaceutical Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. If you are not a pharmacist, you are ineligible to receive CPE credit.
This knowledge-based home study activity “Harm Reduction for Health Care Providers" ACPE #0044-9999-20-008-H01-P, will award 1 contact hours or 0.01 pharmacy education credit.
No partial credit will be awarded.
ACCME Standards for Commercial Support of CME require that presentations be free of commercial bias and that any information regarding commercial products/services be based on scientific methods generally accepted by the medical community. When discussing therapeutic options, speakers are requested to use only generic names. If they use a trade name, then those of several companies should be used. If a presentation includes discussion of any unlabeled or investigational use of a commercial product, speakers are required to disclose this to the participants.
Speaker: Kimberly Sue, MD, Phd
No commercial funds have been received to support this educational activity.
Planning Committee and Speakers Disclosures:
A conflict of interest (COI) occurs when an individual has an opportunity to affect educational content about healthcare products or services of a commercial interest with which she/he has a financial relationship and/or personal relationship. The following planners and presenters of this CNE/CME activity have disclosed no relevant personal or financial relationships with any commercial interests pertaining to this activity:
Emily Scognamiglio, MPH; Angelica Ramirez, MPA; Trang Vu, MD; Monica Barbosu, MD, PhD; Oksana Babiy, BS; Tamara Eis, MS, RN-BC.
Jeffrey Weiss, PhD has had the following relevant financial relationships in the past 12 months that are funded on grants from Gilead to the institution for research, but does not receive any direct funding from Gilead.
Kimberly Sue, MD, PhD has had no relevant financial relationship in the past 12 months with manufacturers of the product or services that may be presented in this activity.
- This online video and post-activity evaluation are 60 min. in length.
- After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
- You must pass the quiz with a score of 80% or higher to receive the CE certificate/credit. You are given two attempts to pass the quiz. If failed you need to watch the presentation again and retake the quiz.
- If successful, you will be provided instructions to print your CE certificate/credit at the completion of this activity.
Bibliographic sources to allow for further study:
- NYS DOH Data Brief: February 2019: Fentanyl Related Deaths in New York State.
- NYC Office of the Chief Medical Examiner and MYC DOHMH Bureau of Vital Statistics; 2000-2017.
- Harm Reduction Coalition. Fentanyl. https://harmreduction.org/issues/fentanyl/
- Harm Reduction Coalition. Understanding Naloxone. https://harmreduction.org/issues/overdose-prevention/overview/overdose-basics/understanding-naloxone/.
- Wejnert C, et al. MMWR Morb Mortal Wkly Rep2016